相关实验视频
Updated: May 2, 2026

06:34
Laser-Induced Chronic Ocular Hypertension Model on SD Rats
Published on: December 4, 2007
11.4K
CB1大麻素受体是光诱导视网膜退化中神经保护的目标
Manuel Soliño1, Ignacio M Larrayoz2, Ester María López1
1Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (IBCN), Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina.
Advances in drug and alcohol research
|February 23, 2024
概括
刺激大麻素受体1 (CB1) 保护光受体免受光诱导的视网膜退化. CB1受体调节为视网膜疾病 (如与年龄相关的黄斑变性) 提供了潜在的神经保护策略.
科学领域:
- 神经科学是一个神经科学.
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 大麻素显示出潜在的神经保护作用.
- 光诱导视网膜退化 (LIRD) 模型人类视网膜疾病.
- 目前正在调查大麻素受体1 (CB1) 在视网膜退化中的作用.
研究的目的:
- 在LIRD的老鼠模型中研究CB1受体调节的神经保护作用.
- 评估CB1主激素和抗剂对光受体生存和质细胞激活的影响.
主要方法:
- 在Sprague Dawley大鼠体内注射CB1激动剂 (ACEA) 或抗剂 (AM251).
- 使用高强度光照射诱导LIRD.
- 使用免疫组织化学 (GFAP),TUNEL测定,西部涂抹 (WB) 和qRT-PCR分析视网膜组织.
主要成果:
- ACEA治疗显著降低了光受体亡,激活了Caspase-3和质反应.
- AM251治疗加剧了光受体亡,激活了Caspase-3和质反应.
- ACEA调节了Bcl-2和CYP1A1的表达,而AM251则影响了Bcl-2,Bad,Bax,AhR,GFAP和TNFα.
结论:
- 在LIRD之前的CB1受体刺激提高了光受体的存活率.
- 调节CB1受体活性为视网膜退化提供了一个有希望的神经保护策略.
- 进一步的研究是有必要的,以探索基于CB1的疗法用于视网膜疾病.
相关概念视频
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
G-Protein Gated Ion Channels
5.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
5.5K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
Neurochemical Transmission: Sites of Drug Action
3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
Opioid Receptors: Overview
7.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K

